首頁 › 前列腺癌 › 加州 › San Francisco
San Francisco, CA 的 前列腺癌 臨床試驗
45 項針對 前列腺癌 的研究正在 San Francisco（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, San Francisco
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
招募中
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
招募中觀察性研究
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
招募中
- University of California San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
招募中2 期
- University of California, San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Kaiser Permanente-San Francisco, San Francisco
Prostate Active Surveillance Study
招募中觀察性研究
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
招募中2 期
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
招募中1 期
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
招募中觀察性研究
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
招募中2 期
- University of California San Francisco, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
招募中1 期
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
招募中1/2 期
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
招募中1 期
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
招募中3 期歡迎健康志工
- University of California San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
招募中1 期
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
招募中觀察性研究
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
招募中2 期
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
招募中1 期
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
招募中2 期
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
招募中1 期
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
招募中2 期
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
招募中觀察性研究歡迎健康志工
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
招募中
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
招募中早期第 1 期
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
招募中
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
招募中3 期
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
招募中觀察性研究
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
招募中1/2 期
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
招募中
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
招募中2 期
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
招募中
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
招募中觀察性研究
- University of California, San Francisco, San Francisco
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
- Dallas, TX36 項研究
San Francisco 的其他研究
- 乳癌43 項研究
- 非小細胞肺癌36 項研究
- 癌症（所有類型）35 項研究
- 心臟衰竭29 項研究
- 轉移性癌症28 項研究
- 肺癌22 項研究
- 黑色素瘤22 項研究
- 胰臟癌20 項研究
- 卵巢癌19 項研究
- 大腸直腸癌18 項研究
- 心血管疾病18 項研究
- 膠質母細胞瘤17 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。